Related Experiment Video
Updated: Feb 17, 2026

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
Prediction of target genes for miR-140-5p in pulmonary arterial hypertension using bioinformatics methods
Fangwei Li1, Wenhua Shi1, Yixin Wan2
1Department of Respiratory Medicine The First Affiliated Hospital of Xi'an Jiaotong University China.
Abstract:
The expression of microRNA (miR)-140-5p is known to be reduced in both pulmonary arterial hypertension (PAH) patients and monocrotaline-induced PAH models in rat. Identification of target genes for miR-140-5p with bioinformatics analysis may reveal new pathways and connections in PAH. This study aimed to explore downstream target genes and relevant signaling pathways regulated by miR-140-5p to provide theoretical evidences for further researches on role of miR-140-5p in PAH. Multiple downstream target genes and upstream transcription factors (TFs) of miR-140-5p were predicted in the analysis. Gene ontology (GO) enrichment analysis indicated that downstream target genes of miR-140-5p were enriched in many biological processes, such as biological regulation, signal transduction, response to chemical stimulus, stem cell proliferation, cell surface receptor signaling pathways. Kyoto Encyclopedia of Genes and Genome (KEGG) pathway analysis found that downstream target genes were mainly located in Notch, TGF-beta, PI3K/Akt, and Hippo signaling pathway. According to TF-miRNA-mRNA network, the important downstream target genes of miR-140-5p were PPI, TGF-betaR1, smad4, JAG1, ADAM10, FGF9, PDGFRA, VEGFA, LAMC1, TLR4, and CREB. After thoroughly reviewing published literature, we found that 23 target genes and seven signaling pathways were truly inhibited by miR-140-5p in various tissues or cells; most of these verified targets were in accordance with our present prediction. Other predicted targets still need further verification in vivo and in vitro.
Insights
MicroRNA (miR)-140-5p is reduced in pulmonary arterial hypertension (PAH). This study identified miR-140-5p targets and pathways, revealing its role in PAH pathogenesis and potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- MicroRNA (miR)-140-5p expression is decreased in pulmonary arterial hypertension (PAH) patients and animal models.
- Understanding miR-140-5p targets is crucial for elucidating PAH mechanisms.
Purpose of the Study:
- To identify downstream target genes and signaling pathways regulated by miR-140-5p in PAH.
- To provide theoretical evidence for the role of miR-140-5p in PAH pathogenesis.
Main Methods:
- Bioinformatics analysis to predict target genes and upstream transcription factors (TFs) of miR-140-5p.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
- Literature review to validate predicted targets and pathways.
Main Results:
- Predicted downstream targets of miR-140-5p are involved in biological regulation, signal transduction, and stem cell proliferation.
- Key signaling pathways implicated include Notch, TGF-beta, PI3K/Akt, and Hippo.
- Validated 23 target genes and seven signaling pathways inhibited by miR-140-5p, largely consistent with predictions.
Conclusions:
- miR-140-5p plays a significant role in regulating key pathways implicated in PAH.
- The identified targets and pathways offer potential avenues for therapeutic intervention in PAH.
- Further in vivo and in vitro studies are needed to confirm remaining predicted targets.
More Related Videos
09:45An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...